Choosing a course is one of the most important decisions you'll ever make! View our courses and see what our students and lecturers have to say about the courses you are interested in at the links below.
Each year more than 4,000 choose NUI Galway as their University of choice. Find out what life at NUI Galway is all about here.
About NUI Galway
About NUI Galway
Since 1845, NUI Galway has been sharing the highest quality teaching and research with Ireland and the world. Find out what makes our University so special – from our distinguished history to the latest news and campus developments.
Colleges & Schools
Colleges & Schools
NUI Galway has earned international recognition as a research-led university with a commitment to top quality teaching across a range of key areas of expertise.
- Research & Innovation
- Business & Industry
- Alumni, Friends & Supporters
At NUI Galway, we believe that the best learning takes place when you apply what you learn in a real world context. That's why many of our courses include work placements or community projects.
Pharmacology and Therapeutics
Discipline overview: the Pharmacology Discipline is actively engaged in a vigorous research programme which is centred around the areas of neuropharmacology (the study of the effects of drugs on the central nervous system), immunopharmacology (the study of the effects of drugs on the immune system), and signalling in vertebrate development.
The Discipline has research links with other national and international centres, including Biochemistry, Anatomy, Physiology, the National Centre for Biomedical Engineering Science , the Regenerative Medicine Institute, and the Network of Excellence for Functional Biomaterialsat NUI Galway, Trinity College Dublin, the University of Nottingham, University College London, Cardiff University, Lund University, Universidad Complutense de Madrid, the University of Pennsylvania, and H/S Lundbeck, Denmark. The research activities of the Discipline are funded from a variety of competitive sources.
PhD (Pharmacology and Therapeutics), part-time
MSc (Pharmacology and Therapeutics), full-time
MD (Pharmacology and Therapeutics), full-time
MD (Pharmacology and Therapeutics), part-time
Applications are made online via the NUI Galway Postgraduate Applications System.
PhD candidates should normally have a high honours standard in a relevant academic discipline at primary degree level or equivalent, together with the support of an academic staff member who is approved by the College to supervise the research in terms of its nature and scope.
MSc (by Research) candidates should normally have a high honours standard in a relevant academic discipline at primary degree level (minimum 2.2 degree) or equivalent, together with the support of an academic staff member who is approved by the College to supervise the research in terms of its nature and scope.
MD candidates should normally have a high honours standard in Medicine from NUI Galway or possess qualification deemed by the Senate of the University to be equivalent. Candidates shall be eligible to register onto the MD programme, three years after obtaining the Degree of Bachelor of Medicine. The application will also require support of an academic staff member who is approved by the College to supervise the research in terms of its nature and scope.
Additional entry requirements: candidates may be required to submit a research proposal for consideration by the School as part of their application.
Who’s Suited to This Course
Current research projects
Current funded research opportunity
Related Student Organisations
Find a Supervisor / PhD Project
If you are still looking for a potential supervisor or PhD project or would like to identify the key research interests of our academic staff and researchers, you can use our online portal to help in that search
- Molecular and cellular biology of vertebrate embryo development
- Antidepressants; novel targets; modulating immune responses
- Non-animal alternatives for toxicological assessment of drugs
- Novel cell, gene and pharmacological therapies for Parkinson's disease
- Molecular mechanisms of intestinal injury, repair and carcinogenesis; inflammatory bowel disease, colon cancer and radiation injury to the intestinal tract
- Caspases, cell death and differentiation;, chemotherapy-induced apoptosis and cancer
- Neurochemical, neuroendocrine and molecular mechanisms underlying pain, anxiety and depression
- Neuropharmacology of cannabinoid and opioid receptors; The endocannabinoid system in pain, anxiety, Parkinson’s disease and neuroimmune function
- Toll-like receptors and the brain-gut axis
Prof. Laurence Egan
Molecular mechanisms of intestinal injury, repair and carcinogenesis; focus on biological functions of transcription factor NF-kappaB; identification and characterization of novel therapeutic targets for inflammatory bowel disease, colon cancer and radiation injury to the intestinal tract.
Prof. John Kelly
Investigation of the mechanism of action of antidepressants and the development of novel targets using animal models; the effects of antidepressants on modulating immune responses; development of non-animal alternatives for toxicological assessment of drugs.
Dr. Maura Grealy
Developmental biology using the zebrafish as a model for cardiovascular development and disease; the role of signalling, via cell-cell adhesion molecules, in heart development; effects of neuroactive drugs on embryo development.
Prof. David Finn
Neurochemical, neuroendocrine and molecular mechanisms underlying pain, anxiety and depression; neuropharmacology of cannabinoid and opioid receptors; imidazoline binding sites, brain monoamines and the stress response; neuroimmune mechanisms of relevance to pain, inflammation and mood disorders.
Dr. Eilís Dowd
Development and functional validation of novel therapies for Parkinson’s disease including novel pharmacological, gene, and cell therapies.
Dr. Howard Fearnhead
The role of caspases in apoptosis and cellular differentiation, investigating how caspases are activated, the downstream effects of activation and the consequences of a failure of the apoptotic program; a particular focus is the role of apoptosis and caspases in cancer chemotherapy.
Dr. Declan McKernan (Programme Director)
The role of Toll-like receptors in brain-gut signalling particularly in visceral hypersensitivity, the effects of stress on intestinal inflammation with focus on TLR expression/activity in distinct regions of the gut as well as the role of Toll-like receptors in psychiatric disorders such as schizophrenia and depression.
Fees: Non EU
EU Part time: Year 1 €3,826 (inclusive of student levy €140) p.a. 2022/23
All students, irrespective of funding, must pay the student levy €140.
T +353 91 492 246